Diane Rehm and her husband John had been married for 54 years when he knew he didn’t want to live another day.
WELCOME TO OUR PARKINSON'S PLACE!
I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.
I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.
I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,
I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.
THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.
PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..
I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.
I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.
THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS
THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!
TRANSLATE
Friday, July 11, 2014
How would you like to Die? Would you want the Doctor's to help you or what? This is a personable one as a legal one.
Diane Rehm and her husband John had been married for 54 years when he knew he didn’t want to live another day.
Thursday, July 10, 2014
New six-minute test could offer a way of identifying early stage Parkinson's disease for the first time
![]() |
| A new six-minute test could diagnose Parkinson's disease in its early stages. Michael J. Fox (pictured) was diagnosed with the disease in 1991 |
More...
Read more: http://www.dailymail.co.uk/health/article-2655259/New-six-minute-test-offer-way-identifying-early-stage-Parkinsons-disease-time.html#ixzz3788vJoAZ
Follow us: @MailOnline on Twitter | DailyMail on Facebook
Margie's Journal: Parkinson's Information: Studies Show Cannabis Relieves Symptoms Of Parkins...
Studies Show Cannabis Relieves Symptoms Of Parkinson’s Disease
for Parkinson’s disease have been conducted since
the seventies, due to the important number of
patients suffering from the illness reporting
an improvement of their symptoms following
the consumption of cannabis.
Motor symptoms
studies, as they constitute the most visible and
most debilitating disorders in relation with
Parkinson’s disease.
As early as the eighties, cannabinoids have been shown to alleviate dystonia, dyskinesia, and akinesia,
all of them motor symptoms which have been known to impact certain Parkinson’s patients. For
instance, controlled doses of synthetic cannabinoids have been able to reduce dyskinesia in patients
suffering
from Parkinson’s disease or Parkinsonism for years by 30%. Incidentally, medicinal cannabis as
well as cannabis extracts-based medications are already being used to treat general spasticity in the
context of other conditions such as multiple sclerosis or Gilles de la Tourette’s syndrome.
Neurodegeneration
is the origin of the aforementioned motor symptoms – has also been relatively active, with a few break
through studies published during the previous decade. The neuroprotective properties of cannabinoids
had already been proven on many occasions, and the impact it could have on Parkinson’s disease
was confirmed as well .
In 2004, a research laboratory injected rats with an agonist of Tetrahydrocannabinol (THC), one of the
major psychoactive substances of cannabis, followed by the injection of a toxin triggering an animal version
of Parkinson’s. Upon testing of these rats in parallel with a control group of healthy subjects,
researchers observed that their brains were virtually indistinguishable. In a second series of tests, other
rats were this time first injected with the toxin, then with the THC agonist, with positive results as well,
especially when THC was combined with Cannabidiol (CBD), a non-psychoactive cannabinoid known
for its medicinal properties. In human terms, the second test suggested that cannabinoids intake could
slow down the progression of the disease for several years.
Recent advances
curative treatment has been developed, partly due to the lack of availability of medicinal cannabis dedicated
to research. This is why the aforementioned studies have so far been considered with relative
caution, especially since it was observed that an excessive dose of cannabis could reverse its own effects
and temporarily worsen some of the motor symptoms. These results were however partly linked to the
relative inefficacy of clinical tests conducted with synthetic cannabinoids, as well as the lack of familiarity
of the subjects tested with medicinal marijuana or cannabis extracts-based medication.
many observational studies were published, focusing on patients already self-medicating with cannabis.
The tests measured their reaction to a “dose” of medicinal cannabis, once again with positive outcomes
in regards to motor symptoms as well as non-motor symptoms. Patients participating to the study
reported that a “dose” of cannabis could relieve them for a period of 2 to 3 hours.
the United States.
Walking improves mood, eases fatigue in those with Parkinson's disease
Veterans Affairs Medical Center in Iowa City
and colleagues published their findings in the
journal Neurology.
speed monitors, and were asked to keep a diary of their exercise. Some walked in groups,
others on their own. Their average walking speed was 2.9 mph
aerobic walking.
ß-ASARONE INCREASES L-DOPA IN PARKINSON'S DISEASE
Clinical and Experimental Pharmacology and Physiology [2014] Jun 7 [Epub ahead of print]
(L.Huang, M.Deng, S.Zhang, Y.Fang, L.Li)
decarboxylase inhibitor. In Sinemet, L-dopa is combined with carbidopa. In Madopar,
L-dopa is combined with benserazide. The co-administration of ß-asarone and Levodopa is
being developed as a means of improving the effect of L-dopa even further.
ß-asarone is found in the flowering plant acorus and also in asarum, which is known as wild
ginger. For more information go to Asarone : http://en.wikipedia.org/wiki/Asarone
In animal studies the use of L-dopa in combination with ß-asarone was
compared to the use of existing methods of treating Parkinson's Disease.
Dopamine levels were found to increase in the brain (in the striatum) and in
blood plasma in response to ß-asarone. The co-administration of ß-asarone
and L-dopa could also increase the levels in blood plasma of tryosine
hydroxylase, which is the enzyme responsible for the formation of L-dopa.
Altogether, ß-asarone was found to have an effect on converting L-dopa
into dopamine by modulating the activity of dopamine metabolism.
The mechanism of co-administration of ß-asarone and L-dopa is different from that of
Sinemet and Madopar in the treatment of Parkinson's Disease. So the co-administration of
ß-asarone and L-dopa may be more beneficial to Parkinson's Disease treatment than the
existing methods and so could eventually replace them.
Saturday, July 5, 2014
THE WORLDWIDE PREVALENCE OF PARKINSON'S DISEASE
Movement Disorders [2014] Jun 28 [Epub ahead of print] (T.Pringsheim, N.Jette, A.Frolkis, T.D.Steeves)
Researchers sought to synthesize studies on the prevalence of Parkinson's Disease to obtain an overall view of how the prevalence varies by age, gender, and geographic location. Geographic location was stratified by the following groups : Asia, Africa, South America, Europe / North America / Australia. Data were analyzed by age group, geographic location, and gender.
Analysis of worldwide data showed a rising prevalence of Parkinson's Disease with age, with (per 100,000) : 41 in 40 to 49 year olds, 107 in 50 to 59 year olds, 173 in 55 to 64 year olds, 428 in 60 to 69 year olds, 1087 in 70 to 79 year olds, and 1903 in those aged older than 80.A significant difference was seen in prevalence geographically only for people who were 70 to 79 years old, with a prevalence of 1601 (per 100,000) in people in North America, Europe, and Australia, compared to only 646 (per 100,000) in people from Asia. Differences in prevalence according to gender was found only for people who were 50 to 59 years old, with a prevalence of 41 in females and 134 in males.
Parkinson's Disease prevalence worldwide increases steadily with age. Some differences in prevalence according to geographic location and gender can be detected.



